Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

NOVT PEER ANALYSIS

Novanta Inc — metric-by-metric comparison with peers and the industry median

NOVTNovanta Inc

🇺🇸 USA · NASDAQ · Technology · Scientific & Technical Instruments

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Scientific & Technical Instruments

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
NOVTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
NOVT+13.0%CDA+128.5%HEXA-B-16.8%
Year-to-Date (YTD)
NOVT+24.9%CDA+52.1%HEXA-B-26.9%
1-Year
Split-adjusted
NOVT+13.0%ST+38.8%ESE+77.1%BMI-38.7%VNT-25.2%CGNX+94.8%
Year-to-Date (YTD)
NOVT+24.9%ST+32.7%ESE+70.0%BMI-16.7%VNT-23.2%CGNX+78.7%

Key Metric Comparison

P/E

Lower is better
NOVT113.84CDA61.01HEXA-B9.53Median 43.76

ROE

Higher is better
NOVT5.2%CDA24.3%HEXA-B17.7%Median 9.7%

Net Margin

Higher is better
NOVT5.3%CDA16.9%HEXA-B40.1%Median 12.4%

Revenue Growth

Higher is better
NOVT5.6%CDA29.1%HEXA-B-6.3%Median 6.5%

P/E

Lower is better
NOVT113.84ST132.88ESE27.91BMI32.49VNT9.85CGNX75.73Median 43.76

ROE

Higher is better
NOVT5.2%ST1.7%ESE21.5%BMI19.6%VNT35.0%CGNX9.7%Median 9.7%

Net Margin

Higher is better
NOVT5.3%ST1.3%ESE24.7%BMI14.6%VNT13.4%CGNX13.6%Median 12.4%

Revenue Growth

Higher is better
NOVT5.6%ST-3.0%ESE23.3%BMI5.2%VNT4.1%CGNX13.8%Median 6.5%

All Metrics

Valuation
MetricNOVTCDAHEXA-BInd. Median
P/E113.8461.019.53●43.76
P/B4.6614.071.61●4.29
EV/EBITDA40.1843.196.16●20.78
P/S6.0910.303.82●4.81
Financial Health
MetricNOVTCDAHEXA-BInd. Median
Current Ratio3.56●1.783.441.90
Debt/Equity22.2%●33.0%27.1%32.5%
NetDebt/EBITDA-0.66●0.880.380.87
Profitability
MetricNOVTCDAHEXA-BInd. Median
Net Margin5.3%16.9%40.1%●12.4%
ROE5.2%24.3%●17.7%9.7%
ROA3.4%14.3%●11.4%6.1%
EBITDA Margin14.9%24.3%66.1%●22.2%
Growth + Dividend
MetricNOVTCDAHEXA-BInd. Median
Rev. Growth5.6%29.1%●-6.3%6.5%
NI Growth-23.9%43.9%108.9%●18.2%
Div. Yield—0.8%●0.2%0.4%
Payout—40.3%19.2%26.9%
Valuation
MetricNOVTSTESEBMIVNTCGNXInd. Median
P/E113.84132.8827.9132.499.85●75.7343.76
P/B4.662.25●5.426.143.237.304.29
EV/EBITDA40.1811.2529.98—8.54●42.8720.78
P/S6.091.736.894.731.32●10.314.81
Financial Health
MetricNOVTSTESEBMIVNTCGNXInd. Median
Current Ratio3.56●2.751.453.001.233.551.90
Debt/Equity22.2%99.8%13.4%—154.0%5.0%●32.5%
NetDebt/EBITDA-0.662.880.41—2.52-0.90●0.87
Profitability
MetricNOVTSTESEBMIVNTCGNXInd. Median
Net Margin5.3%1.3%24.7%●14.6%13.4%13.6%12.4%
ROE5.2%1.7%21.5%19.6%35.0%●9.7%9.7%
ROA3.4%0.7%14.6%●14.0%9.8%7.2%6.1%
EBITDA Margin14.9%20.6%23.3%22.7%21.9%23.6%●22.2%
Growth + Dividend
MetricNOVTSTESEBMIVNTCGNXInd. Median
Rev. Growth5.6%-3.0%23.3%●5.2%4.1%13.8%6.5%
NI Growth-23.9%-60.4%161.1%●-2.7%10.5%21.1%18.2%
Div. Yield—1.0%0.1%1.1%●0.4%0.5%0.4%
Payout—144.5%2.7%34.6%3.5%38.8%26.9%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on NOVT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.